NASDAQ:ABIO
ARCA biopharma Stock News
$3.25
+0.0400 (+1.25%)
At Close: Apr 18, 2024
ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders
05:40pm, Wednesday, 09'th Dec 2020
WESTMINSTER, Colo., Dec. 09, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), today announced that its 2020 Annual Meeting of Stockholders, scheduled for Thursday, December 10, 2020 at 9:
ARCA Biopharma gets Fast Track designation for experimental COVID-19 treatment
12:28pm, Monday, 23'rd Nov 2020
Shares of ARCA Biopharma Inc. gained 5.5% in trading on Monday after the company said it received a Fast-Track designation from the Food and Drug Administration for its mid-stage experimental COVID-19
AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation
08:30am, Monday, 23'rd Nov 2020
WESTMINSTER, Colo., Nov. 23, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapi
ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
08:30am, Monday, 02'nd Nov 2020
WESTMINSTER, Colo., Nov. 02, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapi
How to watch the Le Mans 24 Hours online and on TV this weekend
02:51pm, Thursday, 17'th Sep 2020
Everything you need to know about the 88th running of the Le Mans 24 Hours
The Demolition and wrecking market will register an incremental spend of about $ 10 billion, growing at a CAGR of 3.52% during the five-year forecast
We Think ARCA biopharma (NASDAQ:ABIO) Can Afford To Drive Business Growth
12:49pm, Monday, 17'th Aug 2020
We can readily understand why investors are attracted to unprofitable companies. For example, although...
VBL Therapeutics' Cancer Drug, And Other News: The Good, Bad And Ugly Of Biopharma
03:20pm, Thursday, 13'th Aug 2020
VBL Therapeutics reports progress for ovarian cancer drug candidate. ARCA Biopharma announces mid-stage study for COVID-19 candidate.
* ARCA anticipates filing an IND for AB201 for COVID-19 in September 2020 and initiating Phase 2B clinical testing as early as Q4 2020WESTMINSTER, CO / ACCESSWIRE / August 12, 2020 / ARCA biopharma, I
Arca Biopharma Announces Second Quarter 2020 Financial Results and Provides Corporate Update
08:15pm, Wednesday, 05'th Aug 2020
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. * AB201 being developed as a potential treatment for COVID-19 and other RNA virus associated diseases * ARCA anticipates fi
605 Days Later: How ArCoins Got the SEC Go-Ahead as an Ethereum-Traded Treasurys Fund - CoinDesk
08:00am, Wednesday, 29'th Jul 2020
A look inside Arca and TokenSoft’s 605-day crusade to register the first Ethereum blockchain-native ‘40 Act Fund with the SEC.
The Dollar Drop May Have Helped Push Bitcoin Past $11K
11:27am, Tuesday, 28'th Jul 2020
Renewed pessimism about the greenback and the possibility of additional money printing may have pushed Bitcoin to a new 2020 high.
Arca Labs Gets Approval from SEC to Operate Ethereum-Based Fund
12:35pm, Tuesday, 07'th Jul 2020
Arca Labs, a Los Angeles-based money manager, after 2 years got an “Notice of Effectiveness” from the SEC to operate its Treasury Fund.
The University of Colorado Anschutz Medical Campus and ARCA biopharma, Inc. (ABIO) today announced that the paper entitled "Dynamic Regulation of SARS-CoV-2 Binding and Cell Entry Mechanisms in Remode
Crypto Fund Gives Ethereum Tokens Instead of Shares to Investors, And It’s Approved by the U.S. SEC | BTCMANAGER
10:00am, Tuesday, 07'th Jul 2020
A 2018-founder crypto firm just got the green light from the U.S. SEC to function as an Ethereum-issuing investment fund on Monday, in a first such structure. Own a Hedge Fund’s Tokens Based in Los
